Investigation Overview
After Cephalon, Inc. disclosed it received a subpoena by the U.S. Postal Service Office of Inspector General in connection with its pain drug Fentora an investigation on behalf of current long term investors over possible breaches of fiduciary duties by certain officers and directors at Cephalon, Inc. was announced. The investigation by a law firm concerns whether certain officers an...
You must register (for free) or login to view the entire investigation.